Click HERE to download the PDF version

The silent 21st century epidemic 

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world, affecting up to 30% of the adult population. This percentage can increase to 70-80% for subjects who are obese and diabetic (1). The disease progresses slowly, over years or even decades, and for 20% of subjects can evolve from simple steatosis to Nonalcoholic steatohepatitis (NASH) (2). Unfortunately, the process is silent and most people with scarring on their liver don’t display symptoms. Right now, any validated biomarkers detectable with a routine blood panel are available. 

You may have no symptoms in the early stages of NASH. 

Most people who have NASH feel fine and don’t know that they have it. As NASH progresses and liver damage gets worse, you may start to have symptoms such as fati ... ...